Dose Intensification of Daunorubicin and Cytarabine during Treatment of Adult Acute Lymphoblastic Leukemia: Results of Cancer and Leukemia Group B Study 19802

PURPOSE: CALGB 19802, a phase II study, evaluated whether dose intensification of daunorubicin and cytarabine could improve disease-free survival (DFS) of adults with acute lymphoblastic leukemia (ALL), and whether high-dose systemic and intrathecal methotrexate could replace cranial radiotherapy fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Stock, Wendy, Johnson, Jeffrey L., Stone, Richard M., Kolitz, Jonathan E., Powell, Bayard L., Wetzler, Meir, Westervelt, Peter, Marcucci, Guido, DeAngelo, Daniel J., Vardiman, James W., McDonnell, Diane, Mrózek, Krzysztof, Bloomfield, Clara D., Larson, Richard A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4220742/
https://ncbi.nlm.nih.gov/pubmed/22744771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27617
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados